95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Maike Trommer1,2,3*†
Sin Yuin Yeo2,4†
Thorsten Persigehl3,4Anne Bunck3,4Holger Grüll2,4Max Schlaak2,5Sebastian Theurich2,6,7Michael von Bergwelt-Baildon2,6Janis Morgenthaler1,3Jan M. Herter1,3,8Eren Celik1,3Simone Marnitz1,2,3
Christian Baues1,2,3- 1Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany
- 2Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany
- 3Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany
- 4Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany
- 5Department of Dermatology and Allergology, Ludwig-Maximilians University Munich, Munich, Germany
- 6Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany
- 7Gene Center, Cancer- and Immunometabolism Research Group, Ludwig-Maximilians University Munich, Munich, Germany
- 8Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
by Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, and Baues C. (2019). Front. Pharmacol. 10:511. doi: 10.3389/fphar.2019.00511
An author name was incorrectly spelled as “Michael von Bergwelt.” The correct spelling is “Michael von Bergwelt-Baildon”. The updated Author Contributions statement appears below.
“MT, SYY, and CB developed the conception and design of the study. MT, SYY, TP, AB, and HG discussed the cases in interdisciplinary panels. MT acquired patient data. MT and SYY organized the database, performed all analyses, and wrote the first draft of the manuscript. SYY, TP, and AB acquired the imaging data. TP, HG, MS, ST, MB-B, JM, JH, EC, SM, and CB contributed to the manuscript. All authors contributed to the revision and read and approved the submitted version.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: abscopal effect, PD-1, radio-immunotherapy, radiotherapy, combination treatment, advanced cancer disease, immune checkpoint inhibition
Citation: Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S and Baues C (2020) Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition. Front. Pharmacol. 10:1615. doi: 10.3389/fphar.2019.01615
Received: 28 November 2019; Accepted: 10 December 2019;
Published: 31 January 2020.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2020 Trommer, Yeo, Persigehl, Bunck, Grüll, Schlaak, Theurich, von Bergwelt-Baildon, Morgenthaler, Herter, Celik, Marnitz and Baues. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Maike Trommer, bWFpa2UudHJvbW1lckB1ay1rb2Vsbi5kZQ==
†These authors have contributed equally to this work